Peptide conjugated, inosine-substituted antisense oligomer compound and method

Details for Australian Patent Application No. 2005247460 (hide)

Owner AVI BioPharma, Inc.

Inventors Iversen, Patrick L.; Hassinger, Jed N.; Weller, Dwight D.

Agent Davies Collison Cave

Pub. Number AU-B-2005247460

PCT Pub. Number WO2005/115479

Priority 11/136,245 23.05.05 US; 60/574,048 24.05.04 US

Filing date 24 May 2005

Wipo publication date 8 December 2005

Acceptance publication date 2 August 2012

International Classifications

A61K 38/00 Medicinal preparations containing peptides

A61K 31/70 - Carbohydrates

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/11 Mutation or genetic engineering - DNA or RNA fragments

C12N 15/113 Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

C12N 15/85 Mutation or genetic engineering - for animal cells

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2005/115479 Priority application(s): WO2005/115479

2 August 2012 Application Accepted

  Published as AU-B-2005247460

18 October 2012 Alteration of Name

  The name of the applicant has been altered to Sarepta Therapeutics, Inc. Amendments 2006

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247465-Absorbent article having a fit guide

2005247453-Estrogen modulation of IFNgamma-mediated conditions and diseases